Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

In Pennsylvania’s first precedent-setting decision regarding hormone replacement therapy mass tort litigation, the Superior Court has revived a plaintiff’s lawsuit by finding that the plaintiff was entitled to an exception to the two-year statute of limitations because she couldn’t have reasonably known of an alleged link between her breast cancer and HRT drugs before the publication of a widely publicized study.

Continue reading

Baxter International Inc., which recalled its blood thinner heparin amid reports of allergic reactions and deaths in 2008, faces at least 30 lawsuits in Chicago by injured people or their estates.

As many as 300 product-liability complaints may be filed in the Illinois state court, according to plaintiffs’ attorney Allen Schwartz. His law firm and two others are working to comply with a judge’s order last year to convert an aggregate lawsuit to individual claims against the Deerfield, Illinois-based company.

Continue reading

– Baxter International Inc., which recalled its blood thinner heparin amid reports of allergic reactions and deaths in 2008, faces at least 30 lawsuits in Chicago by injured people or their estates.

As many as 300 product-liability complaints may be filed in the Illinois state court, according to plaintiffs’ attorney Allen Schwartz of Kralovec, Jambois & Schwartz.

Continue reading

The maker of a popular treatment for severe acne will get a new trial, 10 months after the New Jersey Appellate Division struck down a $2.6 million verdict against it.

Hoffman-LaRoche, Inc., maker of Accutane, is alleged to have caused inflammatory bowel disease in some of the drug’s users in a multi-district litigation proceeding in Atlantic County Superior Court. Andrew McCarrell was awarded $2.6 million in his lawsuit in 2007.

Continue reading

Byetta (exenatide) is a type 2 diabetes drug that is used to control blood sugar levels. It is part of a class of medications known as incretin mimetics, which imitate natural hormones that lower blood glucose levels. Last month, the FDA expanded the use of Byetta to a stand-alone diabetes treatment, but insisted that warnings about the risk of pancreatitis from Byetta be added to the label and will require additional studies.

Continue reading

What happens to women after they get a cholecystectomy for gallstones after taking Yaz?
Bile is an important part of digesting fats, and following Yaz gallbladder removal surgery, problems can occur such as bloating and diarrhea. Bile is still produced by the liver, but now bile is continuously released in into the intestine. Problems can occur when eating a meal that is high in fat content since there may not be enough bile in the intestine to adequately handle the normal absorption process.

Continue reading

A federal appeals court reinstated more than 100 lawsuits against drug companies filed by women or their surviving relatives who claimed that hormone replacement therapy caused breast cancer.

The 8th U.S. Circuit Court of Appeals in St. Louis overturned a 2008 district court ruling that had blocked almost all of the suits from being sent back to state court in Minnesota and dismissed most of the lawsuits that were being heard in Little Rock.

Continue reading

The FDA has warned Amylin Pharmaceuticals that they have made false and misleading statements about the diabetes drug Byetta.

The FDA letter was sent to Amylin Pharmaceuticals, alerting the company that federal regulators were aware of statements made by representatives that provided misleading or false information about the benefits of their product.

Download the FDA Warning Letter here.

Download file

Continue reading

Amgen Inc. and Johnson & Johnson face a review of their top-selling anemia drugs by an advisory panel for the U.S. Food and Drug Administration.

The FDA will ask its advisers to evaluate whether lower doses would avoid increased risks of blood clots and heart attacks in patients with chronic kidney disease. The panel was announced in a New England Journal of Medicine commentary.

Continue reading

For John Norrie, the recall of his HP Pavilion Notebook computer came too late.

The laptop allegedly overheated, causing a fire that ripped through Norrie’s Plymouth MA home in November 2006 while he was sleeping. The house was destroyed and Norrie suffered serious injuries in the process of escaping.

Continue reading

Contact Information